Supplementary Materials

This PDF file includes:

  • Fig. S1. DAP12 deficiency does not influence zymosan-induced neutrophil recruitment in the mouse model of dorsal air pouch inflammation.
  • Fig. S2. sCD300b is not involved in zymosan-induced neutrophil accumulation in the mouse model of dorsal air pouch inflammation.
  • Fig. S3. Both L-NAME and 1400 W dihydrochloride reduce neutrophil recruitment and the amounts of NO, LTB4, KC, and MIP-2 in the air pouches of zymosan-treated WT mice.
  • Fig. S4. An Ab against Gr-1 decreases the number of neutrophils recruited to air pouches in response to zymosan.
  • Fig. S5. Pretreatment with clodronate liposomes decreases the number of inflammatory DCs, but not of macrophages, in the air pouch exudates of zymosan-treated WT mice.
  • Fig. S6. Pretreatment with clodronate liposomes reduces the amounts of KC and MIP-2 in the air pouch exudates of WT mice to levels comparable to those in CD300b−/− mice.
  • Fig. S7. Phytosphingosine is present in zymosan.
  • Fig. S8. CD300b deficiency does not affect the phagocytosis of zymosan by GM/IL-4–DCs.
  • Fig. S9. Delipidation of zymosan decreases the number of neutrophils recruited to the air pouches of zymosan-treated WT mice.

[Download PDF]